Article
Gene therapy for monogenic disorders of the bone marrow
5 Jun 2015
Abstract excerpt
Ex-vivo gene transfer of autologous haematopoietic stem cells in patients with monogenic diseases of the bone marrow has emerged as a new therapeutic approach, mainly in patients lacking a suitable donor for transplant. The encouraging results of initial clinical trials of gene therapy for primary immunodeficiencies were tempered by the occurrence of genotoxicity in a number of patients. Over the last decade,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
